SequelSEC

RxSight, Inc. RXST

Ophthalmic Goods · CIK 0001111485 · Fiscal year ends 1231

Revenue
$127.58M
Fiscal year ended 2026-06-30
Operating income
-$55.11M
Fiscal year ended 2026-06-30
Free cash flow
-$27.16M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$503.80MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$12.21Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue3.7×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.8×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Ophthalmic Goods filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio10.95x100th
Gross margin76.6%100th
Revenue YoY growth-3.9%17th
SBC / revenue23.5%83th
Operating margin-35.8%20th
CapEx / revenue2.8%33th
FCF margin-14.4%33th
Net margin-29.0%33th

RxSight, Inc. (RXST) reported revenue of $127.58M and net income of -$46.95M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from RxSight, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Ophthalmic Goods.

Income

RxSight, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$127.58M
Cost of revenue$28.71M
Gross profit$98.87M
Operating income-$55.11M
Net income-$46.95M
Research & development$36.67M
Weighted-average diluted sharesUnavailable
Pretax income-$46.84M
Income tax expense$109.00K
Diluted EPSUnavailable
Selling, general & administrative$117.31M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

RxSight, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$13.35M
Total assets$352.70M
Current assets$327.40M
Total liabilities$89.36M
Current liabilities$80.44M
Total equity incl. NCI$263.34M
Temporary (mezzanine) equityUnavailable
Inventory$37.12M
Accounts receivable$18.52M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$6.34M

Cash flow

RxSight, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$22.73M
Capital expenditures$4.43M
Investing cash flow-$5.12M
Financing cash flow$859.00K
Net change in cash-$27.00M
Stock-based compensation$31.34M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$3.54M

Derived

RxSight, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$27.16M
Gross margin77.5%
Operating margin-43.2%
FCF margin-21.3%
SBC / revenue24.6%
Current ratio4.07x
Revenue YoY growth-13.2%
Net margin-36.8%
R&D / revenue28.7%
CapEx / revenue3.5%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RXST in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-25View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.